Cargando…
Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China
This report serves as a snapshot of the state-of-knowledge in the Asia Pacific (APAC) Hematology Oncology community, and establishes a baseline for longitudinal investigations to follow changes in best practices over time. The objective of this study was to understand the approach to hematologic dis...
Autores principales: | Huang, Xiao Jun, Liu, Kaiyan, Ritchie, David, Andersson, Borje, Lu, Jin, Hou, Jian, Burguera, Adolfo de Fuente, Wang, JianXiang, Yeoh, Allen, Yan, Chenhua, Zhou, Daobin, Tan, Daryl, Kim, Dong Wook, Wu, Depei, Shpall, Elizabeth, Kornblau, Stephen, Neelapu, Sattava, Hongeng, Suradej, Li, Jianyong, Hu, Jiong, Zhang, Lian Sheng, Wang, Michael, Malhotra, Pankaj, Jiang, Qian, Qin, Yazhen, Wong, Raymond, Champlin, Richard, Hagemeister, Frederick, Westin, Jason, Iyer, Swaminathan, Mathews, Vikram, Wang, Yu, Hu, Yu, Xiao, Zhijian, Shao, Zonghong, Orlowski, Robert Z., Chim, Chor Sang, Mulligan, Stephen, Sanz, Miguel, Ozawa, Keiya, Parmar, Simrit, Issaragrisil, Surapol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522281/ https://www.ncbi.nlm.nih.gov/pubmed/28404929 http://dx.doi.org/10.18632/oncotarget.15655 |
Ejemplares similares
-
Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies
por: Pratumkaew, Ponthip, et al.
Publicado: (2021) -
Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
por: Luanpitpong, Sudjit, et al.
Publicado: (2021) -
Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020) -
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies
por: Lekakis, L, et al.
Publicado: (2006) -
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
por: Xu, Lanping, et al.
Publicado: (2018)